ARTICLE | Financial News
Epirus completes follow-on
February 2, 2015 8:00 AM UTC
Epirus Biopharmaceuticals Inc. (NASDAQ:EPRS), Boston, Mass. Business: Biosimilars, Autoimmune, Antibodies Date completed: 2015-01-30 Type: Follow-on Raised: $48 million Shares: 9.6 million Price: $5 S...